Large-scale testing (Phase 3)Study completedNCT00219739What this trial is testingSTI571 ProspectIve RandomIzed Trial: SPIRITWho this might be right forChronic Myeloid Leukemia Poitiers University Hospital 789
Large-scale testing (Phase 3)UnknownNCT00020865What this trial is testingLevofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and NeutropeniaWho this might be right forFever, Sweats, and Hot FlashesInfectionLeukemia+3 more Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00818961What this trial is testingDonor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Northside Hospital, Inc. 36
Early research (Phase 1)Study completedNCT00104975What this trial is testingAlemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Yale University 20
Testing effectiveness (Phase 2)Ended earlyNCT00066417What this trial is testingPeripheral Stem Cell Transplant in Treating Patients With High-Risk LeukemiaWho this might be right forChronic Myeloproliferative DisordersLeukemiaMyelodysplastic/Myeloproliferative Diseases National Heart, Lung, and Blood Institute (NHLBI) 51
Post-approval studies (Phase 4)Study completedNCT00390897What this trial is testingGlivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid LeukaemiaWho this might be right forChronic Myeloid Leukaemia PETHEMA Foundation 360
Early research (Phase 1)Study completedNCT00003243What this trial is testingCombination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableWithdrawnNCT00900120What this trial is testingCollecting and Storing Blood Samples From Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more University of Medicine and Dentistry of New Jersey
Large-scale testing (Phase 3)Study completedNCT00755040What this trial is testingCyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure DisorderWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Vanderbilt-Ingram Cancer Center 164
Testing effectiveness (Phase 2)Ended earlyNCT00003561What this trial is testingInterferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaWho this might be right forLeukemia Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)UnknownNCT00885508What this trial is testingThe Efficacy and Safety of Lenalidomide Combined to Escalating Doses of Chemotherapy in Intermediate-2-or High Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) With Del 5qWho this might be right forMyelodysplastic SyndromeChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia Groupe Francophone des Myelodysplasies 85
Large-scale testing (Phase 3)Study completedNCT02204644What this trial is testingThe Study of the Efficacy and the Safety of Flumatinib vs Imatinib as First Line Treatment in Patients With CMLWho this might be right forCML, CML-CP,MMR,TKI Jiangsu Hansoh Pharmaceutical Co., Ltd. 400
Early research (Phase 1)Study completedNCT00098436What this trial is testingTemozolomide and VNP40101M in Treating Patients With Relapsed or Refractory LeukemiasWho this might be right forLeukemia Vion Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00103844What this trial is testingDasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid LeukemiaWho this might be right forChronic Myeloid LeukemiaPhiladelphia-Positive Myeloid Leukemia Bristol-Myers Squibb 150
Testing effectiveness (Phase 2)WithdrawnNCT00594555What this trial is testingA Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid LeukemiaWho this might be right forChronic Myeloid Leukemia, Blast CrisisAcute Myeloid Leukemia University of Cincinnati 20
Early research (Phase 1)Study completedNCT00079378What this trial is testingDecitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more National Cancer Institute (NCI) 84
Not applicableLooking for participantsNCT06684964What this trial is testingRWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)Who this might be right forChronic Myelogenous Leukemia in Chronic Phase Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT01850004What this trial is testingOpen-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular ResponseWho this might be right forChronic Phase Chronic Myeloid Leukemia Bristol-Myers Squibb 84
Testing effectiveness (Phase 2)Study completedNCT00004052What this trial is testingVaccine Therapy in Treating Patients With Chronic Myelogenous LeukemiaWho this might be right forLeukemia Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT04160052What this trial is testingVenetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic SyndromeWho this might be right forChronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Myelodysplastic Syndrome+2 more M.D. Anderson Cancer Center 51